Grant: Discovery Grants Program - Individual
McGill University
$190,000.00
Advanced Accurate Dosimetry in Radiation Therapy using Calorimetric and Cherenkov Techniques
EF 2023-24
Résumé
In radiation therapy the accuracy of radiation dose delivery to the tumour volume and the level to which critical structures can be spared is directly correlated to treatment outcomes. The uncertainty of the absorbed dose to the patient is determined by uncertainties resulting from several steps in the treatment devices' calibration and the dose delivery. This starts with the determination of absorbed dose in water in clinical reference calibration conditions (reference dosimetry). Clinical application of modern radiation therapy delivery technology, such as TomoTherapy, Cyberknife, magnetic resonance image-guided radiation generators (i.e., MR-Linacs), volumetric modulated arc therapy, scanned proton beam radiation therapy, etc deliver radiation using small fields in high-dose fractions. Hence, the patient treatment conditions are physically and dosimetrically far removed from the standard reference calibration conditions. This has led to uncertainties in radiation delivery. Our NSERC discovery grant program aims to reduce these uncertainties by creating and developing new-generation clinically viable detector technologies, by defining new methodologies and by providing data for clinical dosimetry protocols. Two main detector methodologies are pursued, calorimetry and Cherenkov radiation detection in three main research objectives: (1) to develop a miniature `Aerrow' graphite probe calorimeter to address calibration of clinical small photon beams and proton beams; (2) to address inconsistencies in the reference dosimetry of kV intraoperative radiation beams using the Aerrow; (3) to develop a Cherenkov-radiation dosimeter technique suitable for in-situ clinical dosimetry. The impact of this program is to bring overall better consistency, conceptual clarity and improved accuracy to the dosimetry of small and nonstandard beams. Improved accuracy in the long term will lead to better outcomes. Our program builds on a track record of practice-changing dosimetry successes with some of our technologies to become available to end-users for testing and implementation.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2019-06746
Name nom
Seuntjens, Jan
Department département
Medical Biophysics - Medical Biophysics
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
190000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical engineering
Research subject en
Génie biomédical
Research subject fr
Génie biomédical
Application title
Advanced Accurate Dosimetry in Radiation Therapy using Calorimetric and Cherenkov Techniques
Keyword
absorbed dose calorimetry; cross section data for Monte Carlo; device development; dosimetric uncertainties; ionization chambers; light ion beams; Monte Carlo radiation transport; numerical simulations; radiation measurement; small field dosimetry
Application summary
In radiation therapy the accuracy of radiation dose delivery to the tumour volume and the level to which critical structures can be spared is directly correlated to treatment outcomes. The uncertainty of the absorbed dose to the patient is determined by uncertainties resulting from several steps in the treatment devices' calibration and the dose delivery. This starts with the determination of absorbed dose in water in clinical reference calibration conditions (reference dosimetry). Clinical application of modern radiation therapy delivery technology, such as TomoTherapy, Cyberknife, magnetic resonance image-guided radiation generators (i.e., MR-Linacs), volumetric modulated arc therapy, scanned proton beam radiation therapy, etc deliver radiation using small fields in high-dose fractions. Hence, the patient treatment conditions are physically and dosimetrically far removed from the standard reference calibration conditions. This has led to uncertainties in radiation delivery. Our NSERC discovery grant program aims to reduce these uncertainties by creating and developing new-generation clinically viable detector technologies, by defining new methodologies and by providing data for clinical dosimetry protocols. Two main detector methodologies are pursued, calorimetry and Cherenkov radiation detection in three main research objectives: (1) to develop a miniature `Aerrow' graphite probe calorimeter to address calibration of clinical small photon beams and proton beams; (2) to address inconsistencies in the reference dosimetry of kV intraoperative radiation beams using the Aerrow; (3) to develop a Cherenkov-radiation dosimeter technique suitable for in-situ clinical dosimetry. The impact of this program is to bring overall better consistency, conceptual clarity and improved accuracy to the dosimetry of small and nonstandard beams. Improved accuracy in the long term will lead to better outcomes. Our program builds on a track record of practice-changing dosimetry successes with some of our technologies to become available to end-users for testing and implementation.